Federated Hermes
BIOA

Federated Hermes’s BioAge Labs BIOA Stock Holding History

Federated Hermes’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-184
Closed -$1.08K – 2239
2025
Q3 		$1.08K Sell
184
-814
-82% -$3.81K ﹤0.01% 2067
2025
Q2 		$4.12K Buy
+998
New +$4.02K ﹤0.01% 1902

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return

Federated Hermes's BIOA Position: Q4 2025 in Review

Federated Hermes sold out of BioAge Labs (BIOA) in Q4 2025, closing a stake of 184 shares — an estimated $1.08K sold.

Federated Hermes first reported a position in BIOA in Q2 2025 and held it in 2 quarters. The position peaked at $4.12K in Q2 2025. 114 funds tracked by Wall St. Rank hold BIOA as of Q4 2025.

  • Federated Hermes reported no remaining BioAge Labs position as of Q4 2025 after selling out during the quarter.
  • Federated Hermes sold 184 BioAge Labs shares in Q4 2025, an estimated $1.08K.
  • Federated Hermes first reported a position in BioAge Labs in Q2 2025 and held it in 2 quarters.
  • Federated Hermes's BioAge Labs position peaked at $4.12K in Q2 2025.
  • 114 funds tracked by Wall St. Rank held BioAge Labs as of Q4 2025.

Based on Federated Hermes's 13F filing for Q4 2025, filed 12 Feb 2026.